Medical/Pharmaceuticals

THE ADECCO GROUP Q1 2026 RESULTS

Strong revenue growth, share gains and improved profitability, supported by rigorous execution ZURICH, Switzerland, May 13, 2026 /PRNewswire/ -- AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange HIGHLIGHTS * Accelerating organic revenue growth of +5.3% TDA yoy * Co...

2026-05-13 12:45 2282

Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody

CHENGDU, China, May 12, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) appro...

2026-05-13 08:00 3123

GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class

New kit offers researchers and development teams a meaningful advance in expression speed and output BOSTON, May 13, 2026 /PRNewswire/ -- GenScript Biotech Corporation

2026-05-13 00:19 3028

Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $2.1 Bi...

2026-05-12 22:27 2966

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer

European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and no treatment-related serious adverse events in ESA-refractory lower-risk MDS Dr. Myint, a hematology leader and oncology drug-development executive, joins Halia ...

2026-05-12 20:39 2779

Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI

SUZHOU, China, May 12, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine ("Insilico", 03696.HK). Both parties will leverage their respective core strengths in siRNA drug...

2026-05-12 20:30 3007

Avance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership

The company is recognized for its innovation, scientific expertise, and customer-centric clinical development model in the global biotechnology CRO market SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan

2026-05-12 20:00 2061

New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats

Longitudinal analysis reveals clear gaps in global preparedness against emerging viral threats and future pandemics. CAMBRIDGE, Mass., May 12, 2026 /PRNewswire/ -- New global analysis of antiviral compounds released today has identified a critically thin pipeline of treatments in development tha...

2026-05-12 19:00 1904

HKSH Medical Group Named Asia's first Photon-Counting CT Simulator Reference Site, Bringing Global Impacts on Precision Medicine and Medical Imaging with Siemens Healthineers

HONG KONG, May 12, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and global medical technology leader Siemens Healthineers today signed a collaboration agreement at the "Asia Summit on Global Health", establishing HKSH as Siemens Healthineers' first Photon‑Counting Computed Tomography Simulator ...

2026-05-12 17:31 2708

BGI Genomics joins HGP2 Rare Disease Alliance to Close Rare Disease Care Gap in Asia-Pacific

KUALA LUMPUR, Malaysia, May 12, 2026 /PRNewswire/ -- The HGP2 Rare Disease Alliance of the Asia-Pacific Region (HGP2 RaDiAnce–APAC ) was officially launched in Kuala Lumpur on May 10. YBhg. Datuk Dr. Nor Fariza Binti Ngah, Deputy Director-General of Health...

2026-05-12 16:25 3324

NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-05-11 21:16 5487

Putting humanity back into the focus of 'technonatalism' in assisted reproduction

BEIJING, May 11, 2026 /PRNewswire/ -- Since the world's first IVF baby was born almost 50 years ago, assisted reproductive technologies have advanced spectacularly to help millions of infertile couples to achieve their dreams of parenthood. Yet, despite the power of so-called technonatalism hu...

2026-05-11 17:42 3016

Planning a Group Visit to Medtec Shanghai: A Corporate Buyer's Guide

SHANGHAI, May 11, 2026 /PRNewswire/ -- Sourcing complex medical device components is rarely a solo job. Building a secure supply chain requires direct input from product engineering, quality control, and executive procurement teams. Sending your entire group to theMedtec China exhibition

2026-05-11 14:45 2282

Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa

Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists, along with strategic consulting expertise. TOKYO, May 11, 2026 /PRNewswire/ -- Avalere Health, a global str...

2026-05-11 13:30 1858

ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

TOKYO, May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficient drug discov...

2026-05-11 08:00 2331

ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

SEOUL, South Korea, May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficien...

2026-05-11 08:00 2230

Study pinpoints 45 years as the critical threshold for a significant downturn in male fertility

BEIJING, May 10, 2026 /PRNewswire/ -- Forty-five years has been identified as the critical age threshold at which elevated sperm DNA fragmentation significantly reduces fertility potential in men. High levels of DNA fragmentation, defined as a breakdown of genetic material inside sperm cells, ...

2026-05-10 17:00 2741

South and East Asia identified as hotspots of global warming related impacts on male fertility

BEIJING, May 9, 2026 /PRNewswire/ -- A major new study has shown that South and East Asia dominate patterns of global warming related decline in male fertility with the strongest and most consistent evidence coming from India, Pakistan and the southern parts of China. The effects of increased ...

2026-05-09 15:01 4237

Psychosocial support is vital to help those living with infertility to overcome treatment barriers, including stigmas, myths and taboos about IVF

BEIJING, May 9, 2026 /PRNewswire/ -- Diverse cultural or religious values across the Asia Pacific region mean that many people living with infertility face challenging family or societal attitudes when considering assisted reproductive treatment to achieve their dreams of parenthood. In many c...

2026-05-09 09:00 4508

AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest

ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, designed to improve AAV vector productivity, full-capsid yield, manufacturing efficiency, and...

2026-05-08 20:26 4715
12345 ... 393

Week's Top Stories